Top 10 Companies in the Solid Phase Synthesis Carrier for Peptide Drug Market (2024-2032): Industry Leaders Powering Pharmaceutical Innovations

In Business Insights
June 24, 2025

The Global Solid Phase Synthesis Carrier for Peptide Drug Market was valued at USD 112 million in 2024 and is projected to reach USD 221 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period (2024-2032). This growth is driven by increasing demand for peptide-based therapeutics, advancements in automated synthesis technologies, and the pharmaceutical industry’s shift toward more efficient drug development methods.

As precision medicine gains traction and peptide therapies expand across oncology, metabolic disorders, and cardiovascular applications, the role of high-performance solid phase synthesis carriers becomes increasingly critical. In this analysis, we examine the Top 10 Companies in the Solid Phase Synthesis Carrier for Peptide Drug Industry—a combination of specialized resin manufacturers, chemical innovators, and bioconjugation experts revolutionizing peptide production.


🔟 1. Sunresin

Headquarters: Xi’an, China
Key Offering: Hydroxyl Resins, Amino Resins, Specialty Carriers

Sunresin has emerged as China’s leading manufacturer of SPPS (Solid Phase Peptide Synthesis) carriers, offering a comprehensive portfolio of resins with superior loading capacity and chemical stability. Their products are widely used in both research and commercial peptide production.

Technology Highlights:

  • Developed proprietary high-capacity resins for complex peptide synthesis
  • Significant expansion of manufacturing capabilities in 2023
  • Strategic collaborations with global pharmaceutical companies

Download FREE Sample Report: Solid Phase Synthesis Carrier for Peptide Drug Market – View in Detailed Research Report


9️⃣ 2. Tianjin Nankai Hecheng Science & Technology

Headquarters: Tianjin, China
Key Offering: Wang Resins, Rink Amide Resins, Specialty Linkers

Specializing in peptide synthesis materials, Tianjin Nankai has become a preferred supplier for academic institutions and pharmaceutical companies developing oncology and metabolic disorder treatments.

Technology Highlights:

  • Pioneered cost-effective resin solutions for the Asian market
  • Continuous investment in novel linker technologies

8️⃣ 3. Zhejiang Zhengguang

Headquarters: Zhejiang, China
Key Offering: PEG-Based Resins, Functionalized Carriers

Zhejiang Zhengguang’s expertise in polyethylene glycol (PEG) chemistry has positioned it as a leader in developing specialized carriers for challenging peptide sequences.

Technology Highlights:

  • Developed thermally stable resins for automated synthesizers
  • Expanding into peptide API contract manufacturing

7️⃣ 4. Jiangsu Haipu Functional Materials

Headquarters: Jiangsu, China
Key Offering: Custom Functionalized Resins, Specialty SPPS Media

With a focus on metabolic disease applications, Jiangsu Haipu provides tailored solutions for diabetes and obesity peptide therapeutics.

Technology Highlights:

  • GMP-compliant manufacturing processes
  • Strong capabilities in custom resin development

6️⃣ 5. RawPEG

Headquarters: Alabama, USA
Key Offering: PEG-Based Carriers, Custom Linker Solutions

This U.S.-based specialist focuses on hydrophilic resins for challenging peptide sequences, serving both academic researchers and commercial manufacturers.

Technology Highlights:

  • Specialized in difficult sequence synthesis solutions
  • Strong patent portfolio in PEG chemistry

Download FREE Sample Report: Solid Phase Synthesis Carrier for Peptide Drug Market – View in Detailed Research Report


5️⃣ 6. Merck

Headquarters: Darmstadt, Germany
Key Offering: Premium Synthesis Resins, TentaGel® Products

Through its Novabiochem brand, Merck remains a global leader in high-performance peptide synthesis materials, serving both research and commercial markets.

Technology Highlights:

  • Market leader in premium-grade peptide synthesis materials
  • Continuous innovation in resin architectures

4️⃣ 7. CEM Corporation

Headquarters: North Carolina, USA
Key Offering: Liberty PRIME Resins, Automated Synthesis Systems

CEM Corporation uniquely combines resin manufacturing with peptide synthesizer production, offering integrated solutions for pharmaceutical companies.

Technology Highlights:

  • Patented microwave-assisted synthesis technologies
  • Specialized oncology peptide solutions

3️⃣ 8. Iris Biotech

Headquarters: Marktredwitz, Germany
Key Offering: Functionalized Resins, Custom Solid Supports

This European specialist is renowned for its high-quality functionalized resins and comprehensive catalog of specialty synthesis supports.

Technology Highlights:

  • Extensive research-grade product portfolio
  • Focus on cardiovascular applications

2️⃣ 9. PolyPeptide Group

Headquarters: Switzerland
Key Offering: Commercial-Scale Resins, Turnkey Solutions

Leveraging its position as a leading CDMO, PolyPeptide Group offers optimized carrier solutions for large-scale peptide manufacturing.

Technology Highlights:

  • Integrated from resin development to API production
  • Specialization in complex peptide therapeutics

1️⃣ 10. Bachem

Headquarters: Bubendorf, Switzerland
Key Offering: Premium SPPS Resins, Large-Scale Solutions

Bachem combines decades of peptide manufacturing expertise with tailored carrier solutions for GMP peptide production across clinical and commercial scales.

Technology Highlights:

  • Proprietary technologies for difficult sequences
  • Full-range solutions from research to commercialization

Read Full Report: Solid Phase Synthesis Carrier for Peptide Drug Market – View in Detailed Research Report


🔬 Pharmaceutical Outlook: The Evolving Landscape of Peptide Synthesis

The solid phase synthesis carrier market is undergoing significant transformation as peptide therapeutics gain prominence in drug development pipelines worldwide. While traditional resins maintain dominance, innovation is accelerating across several dimensions.

📈 Critical Industry Trends:

  • Growing demand for specialized carriers capable of handling long, complex peptide sequences
  • Development of environmentally sustainable synthesis supports
  • Integration of intelligent responsive functionalities in solid phase matrices
  • Increasing focus on cost-optimized solutions for commercial-scale peptide API production

Read Full Report: Solid Phase Synthesis Carrier for Peptide Drug Market – View in Detailed Research Report

These market leaders are not merely supplying materials—they are enabling a new era of peptide-based medicines that promise to transform treatment paradigms across multiple therapeutic areas.